LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System.
Journal Information
Full Title: Retina
Abbreviation: Retina
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"S. E. Tedford, C. L. Croissant, M. Walker, R. Rückert and C. Tedford are all employees/contractors of LumiThera."
"The LIGHTSITE III study was supported in part by LumiThera, Inc. and the National Eye Institute (Grant #1R43EY025508-03)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025